#BEGIN_DRUGCARD DB04201

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C16H20N8O8P

# Chemical_IUPAC_Name:
(R)-([(2S,3R,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl {[(2R)-2-azaniumyl-3-(imidazol-4-yl)propanoyl]oxy}phosphonate)

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Histidyl-Adenosine Monophosphate

# HET_ID:
HAM

# Half_Life:
Not Available

# InChI_Identifier:
Not Available

# InChI_Key:
Not Available

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
4201

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
483.3526

# Molecular_Weight_Mono:
483.114171168

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1KMM

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-1.3

# Predicted_LogS:
-2.5

# Predicted_Water_Solubility:
1.57e+00 g/l

# Primary_Accession_No:
DB04201

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
46936920

# PubChem_Substance_ID:
46508578

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT01691

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
NC1=NC=NC2=C1N=CN2[C@@H]1O[C@@H](CO[P@@]([O-])(=O)OC(=O)[C@H]([NH3+])Cc2cncn2)[C@H](O)[C@H]1O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:23:05 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Cytoplasm

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
M11843

# Drug_Target_1_GenBank_ID_Protein:
146372

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
hisS

# Drug_Target_1_Gene_Sequence:
>1275 bp
GTGGCAAAAAACATTCAAGCCATTCGCGGCATGAACGATTACCTGCCTGGCGAAACGGCC
ATCTGGCAGCGCATTGAAGGCACACTGAAAAACGTGCTCGGCAGCTACGGTTACAGTGAA
ATCCGCTTGCCGATTGTAGAGCAGACCCCGCTATTCAAACGTGCGATTGGTGAAGTCACC
GACGTGGTTGAAAAAGAGATGTACACCTTTGAGGATCGCAATGGCGACAGCCTGACTCTG
CGCCCTGAAGGGACGGCGGGCTGTGTACGCGCCGGCATCGAGCATGGTCTTCTGTACAAT
CAGGAACAGCGTCTGTGGTATATCGGGCCGATGTTCCGTCACGAGCGTCCGCAGAAAGGG
CGTTATCGTCAGTTCCATCAGTTGGGCTGCGAAGTTTTCGGTCTGCAAGGTCCGGATATC
GACGCTGAACTGATTATGCTCACTGCCCGCTGGTGGCGCGCGCTGGGTATTTCCGAGCAC
GTAACTCTTGAGCTGAACTCTATCGGTTCGCTGGAAGCACGCGCCAATTACCGCGATGCG
CTGGTGGCATTCCTTGAGCAGCATAAAGAAAAGCTGGACGAAGACTGCAAACGCCGCATG
TACACTAACCCGCTGCGCGTGCTGGATTCAAAAAATCCGGAAGTGCAGGCGCTTCTCAAC
GACGCTCCGGCATTAGGTGACTATCTGGACGAGGAATCTCGTGAGCATTTTGCCGGTCTG
TGCAAACTGCTGGAGAGCGCGGGGATCGCTTACACCGTAAACCAGCGTCTGGTGCGTGGT
CTGGATTACTACAACCGTACCGTTTTCGAGTGGGTGACTAACAGTCTCGGCTCCCAGGGC
ACCGTGTGTGCAGGCGGTCGTTATGACGGTCTTGTGGAACAACTGGGCGGTCGTGCAACA
CCGGCTGTCGGTTTTGCTATGGGCCTCGAACGTCTTGTATTGTTAGTACAGGCCGTTAAT
CCGGAATTTAAAGCCGATCCTGTTGTCGATATATACCTGGTGGCTTCAGGTGCTGATACA
CAATCTGCGGCTATGGCATTAGCTGAGCGTCTGCGTGATGAATTACCGGGCGTGAAATTG
ATGACCAACCACGGCGGCGGCAACTTTAAGAAACAGTTTGCCCGTGCTGATAAATGGGGT
GCCCGCGTTGCTGTGGTGCTGGGTGAGTCTGAAGTGGCTAACGGCACAGCAGTAGTGAAG
GATTTGCGCTCTGGTGAGCAAACGGCAGTTGCGCAGGATAGCGTAGCCGCGCATTTGCGC
ACGTTACTGGGTTAA

# Drug_Target_1_General_Function:
Translation, ribosomal structure and biogenesis

# Drug_Target_1_General_References:
2991272	Freedman R, Gibson B, Donovan D, Biemann K, Eisenbeis S, Parker J, Schimmel P: Primary structure of histidine-tRNA synthetase and characterization of hisS transcripts. J Biol Chem. 1985 Aug 25;260(18):10063-8.
6290315	Eisenbeis SJ, Parker J: The nucleotide sequence of the promoter region of hisS, the structural gene for histidyl-tRNA synthetase. Gene. 1982 May;18(2):107-14.
7556055	Arnez JG, Harris DC, Mitschler A, Rees B, Francklyn CS, Moras D: Crystal structure of histidyl-tRNA synthetase from Escherichia coli complexed with histidyl-adenylate. EMBO J. 1995 Sep 1;14(17):4143-55.
9205837	Yamamoto Y, Aiba H, Baba T, Hayashi K, Inada T, Isono K, Itoh T, Kimura S, Kitagawa M, Makino K, Miki T, Mitsuhashi N, Mizobuchi K, Mori H, Nakade S, Nakamura Y, Nashimoto H, Oshima T, Oyama S, Saito N, Sampei G, Satoh Y, Sivasundaram S, Tagami H, Horiuchi T, et al.: Construction of a contiguous 874-kb sequence of the Escherichia coli -K12 genome corresponding to 50.0-68.8 min on the linkage map and analysis of its sequence features. DNA Res. 1997 Apr 28;4(2):91-113.
9207058	Arnez JG, Augustine JG, Moras D, Francklyn CS: The first step of aminoacylation at the atomic level in histidyl-tRNA synthetase. Proc Natl Acad Sci U S A. 1997 Jul 8;94(14):7144-9.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
3266

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
47030

# Drug_Target_1_Name:
Histidyl-tRNA synthetase

# Drug_Target_1_Number_of_Residues:
424

# Drug_Target_1_PDB_ID:
1KMN

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00587	tRNA-synt_2b
PF03129	HGTP_anticodon

# Drug_Target_1_Protein_Sequence:
>Histidyl-tRNA synthetase
MAKNIQAIRGMNDYLPGETAIWQRIEGTLKNVLGSYGYSEIRLPIVEQTPLFKRAIGEVT
DVVEKEMYTFEDRNGDSLTLRPEGTAGCVRAGIEHGLLYNQEQRLWYIGPMFRHERPQKG
RYRQFHQLGCEVFGLQGPDIDAELIMLTARWWRALGISEHVTLELNSIGSLEARANYRDA
LVAFLEQHKEKLDEDCKRRMYTNPLRVLDSKNPEVQALLNDAPALGDYLDEESREHFAGL
CKLLESAGIAYTVNQRLVRGLDYYNRTVFEWVTNSLGSQGTVCAGGRYDGLVEQLGGRAT
PAVGFAMGLERLVLLVQAVNPEFKADPVVDIYLVASGADTQSAAMALAERLRDELPGVKL
MTNHGGGNFKKQFARADKWGARVAVVLGESEVANGTAVVKDLRSGEQTAVAQDSVAAHLR
TLLG

# Drug_Target_1_Reaction:
ATP + L-histidine + tRNAHis = AMP + diphosphate + L-histidyl-tRNAHis

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
ATP + L-histidine + tRNA(His) = AMP + diphosphate + L-histidyl-tRNA(His)

# Drug_Target_1_SwissProt_ID:
P60906

# Drug_Target_1_SwissProt_Name:
SYH_ECOLI

# Drug_Target_1_Synonyms:
EC 6.1.1.21
HisRS
Histidine--tRNA ligase

# Drug_Target_1_Theoretical_pI:
5.72

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Cytoplasm

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
AP008226

# Drug_Target_2_GenBank_ID_Protein:
55772094

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
hisS

# Drug_Target_2_Gene_Sequence:
>1266 bp
TCACCCGAGGGCCTGGAGGAGGTAGCCCGGAACCTCCTCCCGGCTTAAGCGCACCTGCTC
CCCGGTGGCGAGCCTCTTCAGGGTCACCTCCCCCGCCCGGAGCTCGTCCTCGCCCAGGAA
GCCCGCGAAGGCCGCCCCCCGCTTCAGGGCCTCCTCCAGGCCCTTGGCCGGCTTCCTGGG
GGCGAGGGCGTACTCGGCCCGGAGGCGGGGCCTCAGGGCCTCGGCCAGGTAGAAGGCCTC
CGCCACCGCCTCCTCCGTGAGGGGGATGAGGTAGAGGTCGGGGCCCTTCTCCTCGGGGAG
GCCGAAGCCCTCGGCCTCGAGGGCCAGGGCCACCCGCTCCACCCCGAAGGCGAACCCCAC
CCCGGGGACCCTGGGCCCGCCCAAAAGCTCGGAAAGCCCGTCGTACCGCCCCCCGCCCCC
CAGGGCGGACTGGGCCCCGATCTCCTCGTGGTGCACCTCAAAGGCGGTGCGCACGTAGTA
GTCCAGCCCCCGCACCAAGGCGGGCTCCAGCTCGTAGGGGACGGAAAGCCTTTCCAGGTG
GCGCTCCACCTCTTTGAGGTGGGCCCTCGCCTCCTCCCCCAGGAAGTCCAGCATGGGCCT
CACCCCGAGCTCCTTGAGGAGGGCCTGGTCCCGCTCGCTCTTGGAGTCCAGGATGCGCAT
GGGGTTGAGCTCCAAGCGCTCCTTGGAGTCCTCGGAGAGGGCCTCCCGGTGGGGGGAGAG
GACCTCCCGCAGGTAGGCGTTGTAGCGCGCCCGGTCCTCGGGGTCCCCCACGGAGGAGAG
CTTGACCTTGAGGCGCCTTAGGCCGAGCTCCTTCAGGCACTCGTAGAGGAGGACCACGGC
CTCGGCGTCCAGGATGGGGTTTTCCGAGCCCAAGGCCTCGTAGTTCACCTGGTGGAACTG
GCGGTACCGCCCCTTTTGGGGCCGTTCTGCCCGGAACATGGGCCCCGCCATCCAGAGCCT
CACGGGCTGGGGCCAGACCTTCATCCCGTGCTCCAGGTAGGCCCGGACCATGGCGGCCGT
GCCCTCGGGGCGCAGGGTGAGGGAGCGCCCGCCCCGGTCCTGGAAGGTGAACATCTCCTT
GCGCACGATGTCCGTGGCCGCCCCCACGCCCTTCTCAAAGACCTGGGTTTCCTCAAAGAT
GGGGGTGACGAGCTCCAGGGCCCCCGCCGCCTCCAAGACCTTGCGGGCGGTGGCCACGAT
GCGCTGGTGCATCCTGAGCTCCTTGCCGAAAAGGTCCTTGGTGCCCCGCACGGCCCGAGC
GGTCAT

# Drug_Target_2_General_Function:
Translation, ribosomal structure and biogenesis

# Drug_Target_2_General_References:
9115984	Aberg A, Yaremchuk A, Tukalo M, Rasmussen B, Cusack S: Crystal structure analysis of the activation of histidine by Thermus thermophilus histidyl-tRNA synthetase. Biochemistry. 1997 Mar 18;36(11):3084-94.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
3392

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
47042

# Drug_Target_2_Name:
Histidyl-tRNA synthetase

# Drug_Target_2_Number_of_Residues:
421

# Drug_Target_2_PDB_ID:
1H4V

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF00587	tRNA-synt_2b
PF03129	HGTP_anticodon

# Drug_Target_2_Protein_Sequence:
>Histidyl-tRNA synthetase
MTARAVRGTKDLFGKELRMHQRIVATARKVLEAAGALELVTPIFEETQVFEKGVGAATDI
VRKEMFTFQDRGGRSLTLRPEGTAAMVRAYLEHGMKVWPQPVRLWMAGPMFRAERPQKGR
YRQFHQVNYEALGSENPILDAEAVVLLYECLKELGLRRLKVKLSSVGDPEDRARYNAYLR
EVLSPHREALSEDSKERLELNPMRILDSKSERDQALLKELGVRPMLDFLGEEARAHLKEV
ERHLERLSVPYELEPALVRGLDYYVRTAFEVHHEEIGAQSALGGGGRYDGLSELLGGPRV
PGVGFAFGVERVALALEAEGFGLPEEKGPDLYLIPLTEEAVAEAFYLAEALRPRLRAEYA
LAPRKPAKGLEEALKRGAAFAGFLGEDELRAGEVTLKRLATGEQVRLSREEVPGYLLQAL
G

# Drug_Target_2_Reaction:
ATP + L-histidine + tRNAHis = AMP + diphosphate + L-histidyl-tRNAHis

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
ATP + L-histidine + tRNA(His) = AMP + diphosphate + L-histidyl-tRNA(His)

# Drug_Target_2_SwissProt_ID:
P56194

# Drug_Target_2_SwissProt_Name:
SYH_THET8

# Drug_Target_2_Synonyms:
EC 6.1.1.21
HisRS
Histidine--tRNA ligase

# Drug_Target_2_Theoretical_pI:
6.35

# Drug_Target_2_Transmembrane_Regions:
None

#END_DRUGCARD DB04201
